Rivaroxaban-Mepha 20 mg, Filmtabletten - 14 Swissmedic Key 68439008 Registration Holder Mepha Pharma AG Name Rivaroxaban-Mepha 20 mg, Filmtabletten Date of registration 15.03.2022 Original/Generic Generic Introduction of Sequence 15.03.2022 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 14.03.2027 Index Therapeuticus (BSV) 06.03.40. Show package size 14 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 9.71 Limitation Yes Limitation text
Deductible 10 % Consumer price 27.00 Feedback FB Daily cost GTIN 7680684390081 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 20 mg, natrii laurilsulfas, lactosum monohydricum 167.2 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.19 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 20 mg
BAG: Active Agent Dose Rivaroxabanum 20 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum E 172 color. Hypromellosum Lactose Monohydrate 167.2 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 06.04.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
